Results 161 to 170 of about 21,091 (202)

Safety Profile of Statins: An Umbrella Review of Systematic Reviews and Meta-analyses. [PDF]

open access: yesEur Cardiol
Penedones A   +5 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Lovastatin

Archives of Internal Medicine, 1990
Two patients who developed hypoprothrombinemia and bleeding due to lovastatin-warfarin drug interaction are described. Because of the wider use of lovastatin and warfarin, heightened clinical awareness of this potentially serious interaction must be publicized.
  +6 more sources

Lovastatin for Hypercholesterolemia

Drug Intelligence & Clinical Pharmacy, 1988
Lovastatin is the first 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor approved for the treatment of primary hypercholesterolemia. It is indicated as adjunctive therapy to dietary control and should be initiated at 20 mg/d in the evening. With higher dosages, twice-daily dosing is preferred, particularly when the dosage reaches the
F P, Zeller, K C, Uvodich
openaire   +2 more sources

The liver and lovastatin

The American Journal of Cardiology, 2002
The cholesterol-lowering agents, known as statins, have been in use for 15 years and are among the most commonly prescribed drugs. Animal studies and premarketing clinical trials have given signals of hepatotoxicity, primarily minor elevations in serum alanine aminotransferase enzyme (ALT) levels.
openaire   +2 more sources

Home - About - Disclaimer - Privacy